Código QR (código de barras bidimensional)

Clinical outcomes with first-line tislelizumab plus lenvatinib in unresectable hepatocellular carcinoma: a retrospective analysis

Purpose This retrospective analysis aimed to assess the therapeutic efficacy and adverse event profile of tislelizumab combined with lenvatinib in patients with unresectable hepatocellular carcinoma (uHCC), predominantly of hepatitis B virus (HBV) etiology. While this combination has shown promise i...

ver descrição completa

Na minha lista:
Principais autores: Jizong Lin, Qingxun Zhou, Zhicheng Yao, Qingliang Wang, Shilei Xu, Zhiyong Xiong, Xi Dang, Hao Liang, Bo Liu
Formato: Artigo
Idioma:Inglês
Publicado em: PeerJ Inc. 2026-01-01
coleção:PeerJ
Assuntos:
Retrospective analysis
Efficacy
First-line treatment
Hepatocellular carcinoma
Lenvatinib
Tislelizumab
Acesso em linha:https://peerj.com/articles/20591.pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados